Legal & General Group PLC Immunocore Holdings PLC Transaction History

Legal & General Group PLC

  • $440 Billion
  • Q2 2024

A detailed history of Legal & General Group PLC transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Legal & General Group PLC holds 120,517 shares of IMCR stock, worth $3.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
120,517
Previous 36,045 234.35%
Holding current value
$3.78 Million
Previous $2.34 Million 74.38%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$33.78 - $63.75 $2.85 Million - $5.39 Million
84,472 Added 234.35%
120,517 $4.08 Million
Q1 2024

May 14, 2024
SELL
$60.14 - $75.36 $15,035 - $18,840
-250 Reduced 0.69%
36,045 $2.34 Million
Q4 2023

Feb 15, 2024
BUY
$42.85 - $69.5 $368,895 - $598,325
8,609 Added 31.1%
36,295 $2.48 Million
Q3 2023

Nov 14, 2023
BUY
$49.5 - $66.6 $183,744 - $247,219
3,712 Added 15.48%
27,686 $1.44 Million
Q2 2023

Aug 14, 2023
BUY
$48.54 - $61.64 $869,836 - $1.1 Million
17,920 Added 296.0%
23,974 $1.44 Million
Q1 2023

May 15, 2023
BUY
$46.12 - $65.71 $14,020 - $19,975
304 Added 5.29%
6,054 $299,000
Q4 2022

Feb 14, 2023
SELL
$45.51 - $65.08 $436,850 - $624,702
-9,599 Reduced 62.54%
5,750 $328,000
Q3 2022

Nov 14, 2022
SELL
$37.34 - $57.44 $16,541 - $25,445
-443 Reduced 2.81%
15,349 $719,000
Q2 2022

Aug 22, 2022
SELL
$25.46 - $37.72 $167,450 - $248,084
-6,577 Reduced 29.4%
15,792 $589,000
Q4 2021

Feb 14, 2022
SELL
$27.58 - $40.0 $80,202 - $116,320
-2,908 Reduced 11.5%
22,369 $765,000
Q3 2021

Nov 15, 2021
BUY
$27.98 - $40.0 $173,084 - $247,440
6,186 Added 32.4%
25,277 $933,000
Q2 2021

Aug 12, 2021
BUY
$32.22 - $41.5 $615,112 - $792,276
19,091 New
19,091 $725,000

Others Institutions Holding IMCR

# of Institutions
150
Shares Held
39.8M
Call Options Held
157K
Put Options Held
135K
View Full List

About Immunocore Holdings plc

IMCR Quotes by TradingView
  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.38B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email